Top 20 Shareholders 31st October 2018
Top_Holder_-_Detail_-_Single_Date October
Drug Reformulation Play With Significant Potential
2018 11 05 PharmAust report from NDF Research This report has been commissioned and paid for by PharmAust (Company) and has been prepared by NDF Research, an Authorised Representative of BR Securities Australia Pty Ltd. The report solely reflects the views of Pitt Street Research. Any opinions, forecasts, recommendations or forward-looking statements in the report…
GMP Method for PharmAust Analogue Pipeline
181029_GMP_AAD_Manufacture
PharmAust Progresses Monepantel Tablet Program for Cancer
181015_Tablet_Update
Notice of Annual General Meeting: November 9
181010_Notice of Annual Meeting
October 8, Director’s Interest
181008_Director's Interest_
Top 20 Shareholders October 2018
top_holder_-_detail_-_single_date September
Mr Neville Bassett AM Appointed to PharmAust Board
181002_Neville Bassett
PharmAust 2018 Annual Report
181001_Annual_Report